ProfileGDS5678 / 1438048_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 81% 78% 81% 76% 78% 81% 77% 79% 79% 82% 84% 81% 84% 81% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 15.7234281
GSM967853U87-EV human glioblastoma xenograft - Control 25.4412978
GSM967854U87-EV human glioblastoma xenograft - Control 35.8127481
GSM967855U87-EV human glioblastoma xenograft - Control 45.289876
GSM967856U87-EV human glioblastoma xenograft - Control 55.4693578
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 15.6265281
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 25.1519577
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 35.5523379
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 45.4626879
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 15.9922182
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 26.2226284
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 35.8500581
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 46.1990684
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 55.8057181